Hao‐Wei Teng
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 40
- Colorectal Cancer Treatments and Studies 19
- Cancer Treatment and Pharmacology 5
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 4
-
- Genetic factors in colorectal cancer 8
- Co-authors
- Jeng‐Kai Jiang (33 shared papers)Yuan‐Tzu Lan (27 shared papers)Wei‐Lun Hwang (8 shared papers)Shung-Haur Yang (27 shared papers)Shung‐Haur Yang (9 shared papers)Shih‐Ching Chang (22 shared papers)Chun‐Chi Lin (27 shared papers)Wei-Shone Chen (24 shared papers)
- Journals
- Journal of Gastrointestinal Surgery (6 papers)Annals of Hematology (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)Frontiers in Oncology (3 papers)Scientific Reports (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Hao‐Wei Teng
80 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 114
- Oncology 916
- Cancer Research 362
- Hepatology 133
- Pathology and Forensic Medicine 221
- Molecular Biology 709
Countries citing papers authored by Hao‐Wei Teng
This map shows the geographic impact of Hao‐Wei Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao‐Wei Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao‐Wei Teng more than expected).
Fields of papers citing papers by Hao‐Wei Teng
This network shows the impact of papers produced by Hao‐Wei Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao‐Wei Teng. The network helps show where Hao‐Wei Teng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao‐Wei Teng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 264 | |
| 2 | 2014 | 240 | |
| 3 | 2019 | 110 | |
| 4 | 2008 | 97 | |
| 5 | 2012 | 75 | |
| 6 | 2011 | 64 | |
| 7 | 2024 | 62 | |
| 8 | 2018 | 57 | |
| 9 | 2007 | 56 | |
| 10 | 2012 | 55 | |
| 11 | 2010 | 53 | |
| 12 | 2014 | 49 | |
| 13 | 2016 | 48 | |
| 14 | 2006 | 41 | |
| 15 | 2021 | 35 | |
| 16 | 2010 | 33 | |
| 17 | 2011 | 33 | |
| 18 | 2011 | 33 | |
| 19 | 2020 | 32 | |
| 20 | 1992 | 30 |
About Hao‐Wei Teng
Hao‐Wei Teng is a scholar working on Oncology, Pathology and Forensic Medicine, Hematology, Pulmonary and Respiratory Medicine and Hepatology, having authored 83 papers that have together received 2.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Genetic factors in colorectal cancer (8 papers), Cancer Treatment and Pharmacology (5 papers), Gastric Cancer Management and Outcomes (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (916 citations), Cancer Research (362 citations), Hepatology (133 citations), Pathology and Forensic Medicine (221 citations) and Molecular Biology (709 citations). Hao‐Wei Teng has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jeng‐Kai Jiang, Yuan‐Tzu Lan, Wei‐Lun Hwang, Shung-Haur Yang, Shung‐Haur Yang, Shih‐Ching Chang, Chun‐Chi Lin, Wei-Shone Chen, Hsei–Wei Wang and Hsin‐Yi Lan. Their work appears in journals such as Journal of Gastrointestinal Surgery, Annals of Hematology, Journal of Cancer Research and Clinical Oncology, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.